BMSN. HemaXellerate II™ HemaXellerate II
Post# of 5066
[Regen BioPharma is currently in the preclinical stage of development for HemaXellerate II]
HemaXellerate II is intended to be a universal donor endothelial cell based therapeutic and is intended to be manufactured by obtaining cells from a part of the placenta called the “vascular lobules”. The cells are processed and utilized for the purpose of stimulating bone marrow hematopoetic stem cell repair and proliferation. The mechanism of action for HemaXellerate II is similar to HemaXellerate I whereby the harvested and processed cells would produce growth factors which would mediate the therapeutic effects of the product.
HMMM. Hema II. the next blockbuster drug waiting in the wings behind Hema and DcellVAX. Wait for the news or sing the blues
Ballistic Missile Soars North
BMSN. Post by Sizz. BMSN.